Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo
David Erlinge(Lund University), Lars Wallentin(Uppsala University), Stefan James(Uppsala University), Kenneth J. Winters(Eli Lilly (United States)), Agneta Siegbahn(Uppsala University), Christoph Varenhorst, John T. Brandt(Universitätsklinikum Würzburg), Oscar Ö. Braun(Lund University), Joseph A. Jakubowski(Indiana Biosciences Research Institute), Atsuhiro Sugidachi(Daiichi Sankyo (United Kingdom))
Cited by 216
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k